Date published: 2026-8-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

γ Enolase Double Nickase Plasmid (h): sc-400763-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • γ Enolase Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • γ Enolase Double Nickase Plasmid (h) and γ Enolase Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting ENO2. One or both designs may be available
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: γ Enolase Antibody (D-7): sc-376375
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    γ Enolase Double Nickase Plasmid (h)

    sc-400763-NIC
    20 µg
    $410.00

    γ Enolase Double Nickase Plasmid (h2)

    sc-400763-NIC-2
    20 µg
    $410.00

    ENO2 encodes human γ-enolase (neuron-specific enolase), a glycolytic enzyme that catalyzes the interconversion of 2-phosphoglycerate and phosphoenolpyruvate, linking glucose metabolism to cellular ATP production. Beyond glycolysis, ENO2 expression is associated with neuronal differentiation, synaptic activity, and metabolic adaptation in excitable tissues, and it is commonly used as a marker of neuroendocrine and neuronal lineage states. Altered ENO2 regulation has been connected to metabolic reprogramming, oxidative stress responses, and changes in cell survival signaling observed in diverse neurobiology and oncology models. These features make ENO2 a useful node for studying glycolytic flux, lineage specification, and metabolism-associated phenotypes in human cells.

    γ Enolase Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the ENO2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within ENO2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt ENO2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of ENO2-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.